GlycoMimetics

is a Maryland-based clinical-stage biotechnology company that develops and commercializes glycobiology therapies for cancer and inflammatory diseases...
Read more
GlycoMimetics CEO: Harout Semerjian

CEO

Harout Semerjian

CEO Approval Rating

83/100

Annual Revenue
$ < 1M
Employees
50
Funding
$119.8M
Acquisitions
1

GlycoMimetics Competitors

1Inovio
2Xalud
3Vera
4Supernus
5Vanda
6Genentech
7Galecto
8AbbVie
9Biogen
10Gilead

Trending Companies